SBIR/STTR Research Award

Targeted Aptamer Probes for Nucleic Acid Detection

Award identifier 93eae9a2847cb887b1d17298e41c15f1c7d167574b1b6a6296064de18fa1390aAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$106,257

Program and phase

STTR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Aptalogic, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
EWN1YJ67XK31
Solicitation number
Not reported
Topic code
Not reported

Research abstract

The eventual goal of the current research is to develop probes for in vivo imaging of gene expression and for in vivo targeting of cells for killing or remediation. The current proposal describes a novel nucleic acid probe design that will provide the basis of the new technology required for these applications. These probes are also expected to be a major improvement over current probes for applications such as the analysis of bacterial and other contamination of foods and in the analysis of specific gene expression in cell and tissue samples. We call these "Targeted Revealed Aptamer Probes" (TRAPS). The basic innovation in the proposed TRAP design is the inclusion of an attenuated aptamer that is revealed on hybridization with a target nucleic acid. In the current proposal, the following specific aims are proposed: * Produce a basic TRAP probe. Determine that the TRAP probe only binds its ligand when the probe is hybridized with complementary RNA. Test for proportionality between the amounts of complementary RNA and ligand binding to the probe. Test for specificity of the interaction between the TRAP and the target RNA. * Produce a capture TRAP probe that can be used in capture assays and test its efficacy. PROPOSED COMMERCIAL APPLICATIONS: Initially, these probes are expected to be a major improvement on the current nucleic acid probes used for detection of DNA and RNA sequences such as in the analysis of bacterial and other contamination of foods and in the analysis of specific gene expression in cell and tissue samples. After further development, the probes will be used for in vivo imaging of gene expression and for targeting cells in vivo so that they can be killed or remediated.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

11 SBIR/STTR records share this UEI (2001–2019). Reported award amounts total $4,338,423. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.